Oncology

OS Therapies Accelerates OST-HER2 Toward 2026 BLA with Strong Q3 Progress

Dateline: November 17, 2025 — New York, NYOS Therapies reported its third-quarter 2025 financial results and issued a comprehensive...

By cGxPwire Editor
November 17, 2025

Bio-Pharma

ORIC Pharmaceuticals Q3 Results Highlight Clinical Pipeline Strength

SOUTH SAN FRANCISCO, CA — November 13, 2025 — ORIC Pharmaceuticals reported its third-quarter 2025 financial and clinical results,...

By cGxPwire Editor
November 14, 2025

Bio-Pharma

Fortress Biotech Reports Strong Q3 Growth and Pipeline Progress

MIAMI, FL — November 14, 2025 — Fortress Biotech announced its third-quarter 2025 financial results, highlighting sustained revenue growth,...

By cGxPwire Editor
November 14, 2025

Bio-Pharma

Pelthos Therapeutics Reports Solid Q3 FY2025 Financial Results

SEATTLE, WA – November 13, 2025 — Pelthos Therapeutics released its third-quarter fiscal 2025 financial results, highlighting strong R&D...

By cGxPwire Editor
November 13, 2025

M&A

Day One Biopharma Acquires Mersana to Advance ADC Pipeline

BRISBANE, CA – November 13, 2025 — Day One Biopharmaceuticals announced a definitive agreement to acquire Mersana Therapeutics in...

By cGxPwire Editor
November 13, 2025

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

Bio-Pharma

Cogent Biosciences Secures $475M to Advance Precision Therapies

Dateline — WALTHAM, Mass. and BOULDER, Colo., November 11, 2025:Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company developing precision...

By cGxPwire Editor
November 12, 2025

Bio-Pharma

Alpha-9 Oncology Appoints Paul Blanchfield as CEO to Drive Radiopharma Growth

BOSTON and VANCOUVER, BC, November 10, 2025 — Alpha-9 Oncology, Inc., a clinical-stage radiopharmaceutical company pioneering targeted cancer therapies,...